Brawn Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

16.49

22.23

8.62

34.98

49.62

Operating profit

-1.53

-0.30

-2.01

-0.60

0.73

Interest

-

0.01

0.06

0.04

0.05

Gross profit

-1.44

-0.30

-2.06

-0.33

0.85

EPS (Rs)

-5.15

-2.89

-5.48

-1.84

1.97

Other income

0.09

0.01

-

0.31

0.17

Stock adjustment

-1.23

-0.07

-4.47

0.13

-0.05

Raw material

-

-

-

1.64

-

Power and fuel

-

-

-

-

-

Employee expenses

1.40

1.40

1.80

2.36

3.08

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

17.85

21.20

13.29

31.44

45.85

Provisions made

-

-

-

-

-

Depreciation

0.10

0.11

0.05

0.03

0.03

Taxation

-

0.46

-0.47

0.19

0.23

Net profit / loss

-1.54

-0.87

-1.64

-0.55

0.59

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

3.00

3.00

3.00

3.00

3.00

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-9.27

-1.37

-23.27

-1.71

1.48

GPM (%)

-8.71

-1.36

-23.94

-.93

1.72

NPM (%)

-9.31

-3.90

-19.07

-1.56

1.19